{"id":563814,"date":"2026-09-19T22:56:41","date_gmt":"2026-09-19T20:56:41","guid":{"rendered":"https:\/\/medizinonline.com\/une-immunomodulation-de-premier-ordre-alliee-a-la-praticite-les-donnees-disponibles-a-ce-jour-sont-convaincantes\/"},"modified":"2026-09-19T22:56:46","modified_gmt":"2026-09-19T20:56:46","slug":"une-immunomodulation-de-premier-ordre-alliee-a-la-praticite-les-donnees-disponibles-a-ce-jour-sont-convaincantes","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/une-immunomodulation-de-premier-ordre-alliee-a-la-praticite-les-donnees-disponibles-a-ce-jour-sont-convaincantes\/","title":{"rendered":"Une immunomodulation de premier ordre alli\u00e9e \u00e0 la praticit\u00e9 : les donn\u00e9es disponibles \u00e0 ce jour sont convaincantes"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>La compr\u00e9hension de la physiopathologie du psoriasis s&#8217;est consid\u00e9rablement am\u00e9lior\u00e9e ces derni\u00e8res ann\u00e9es et de nombreuses cibles th\u00e9rapeutiques ont \u00e9t\u00e9 identifi\u00e9es. Cela a r\u00e9cemment abouti au d\u00e9veloppement de principes actifs innovants sous forme de m\u00e9dicaments par voie orale, parmi lesquels il convient de mentionner tout particuli\u00e8rement le zasocitinib \u2013 un inhibiteur de TYK2 \u2013 et l\u2019icotrokinra \u2013 un peptide oral qui inhibe s\u00e9lectivement le r\u00e9cepteur de l\u2019interleukine-23 (IL-23), m\u00e9ritent d\u2019\u00eatre particuli\u00e8rement mis en avant.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fune-immunomodulation-de-premier-ordre-alliee-a-la-praticite-les-donnees-disponibles-a-ce-jour-sont-convaincantes%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La compr\u00e9hension de la physiopathologie du psoriasis s&#8217;est consid\u00e9rablement am\u00e9lior\u00e9e ces derni\u00e8res ann\u00e9es et de nombreuses cibles th\u00e9rapeutiques ont \u00e9t\u00e9 identifi\u00e9es. Cela a r\u00e9cemment abouti au d\u00e9veloppement de principes actifs&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fune-immunomodulation-de-premier-ordre-alliee-a-la-praticite-les-donnees-disponibles-a-ce-jour-sont-convaincantes%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":563818,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Options th\u00e9rapeutiques orales innovantes dans le traitement du psoriasis : l\u2019icotrokinra et le zasocitinib  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11549,11362,11527,11535,11505],"tags":[100011,84526,100012,20110,84524,95016,14035,95020],"powerkit_post_featured":[],"class_list":["post-563814","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-dermatologie-et-venerologie","category-etudes","category-rapports-de-congres","category-rhumatologie","tag-iconic-total","tag-icotrokinra-fr","tag-latitude-pso-3001-3002","tag-modulation-immunitaire","tag-peptide-oral","tag-produits-prets-a-consommer","tag-psoriasis-fr-2","tag-zasocitinib","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-10-02 06:51:04","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":563822,"slug":"immunomodulazione-di-primordine-unita-alla-praticita-i-dati-disponibili-finora-sono-convincenti","post_title":"Immunomodulazione di prim\u2019ordine unita alla praticit\u00e0: i dati disponibili finora sono convincenti","href":"https:\/\/medizinonline.com\/it\/immunomodulazione-di-primordine-unita-alla-praticita-i-dati-disponibili-finora-sono-convincenti\/"},"pt_PT":{"locale":"pt_PT","id":563831,"slug":"imunomodulacao-de-primeira-classe-aliada-a-praticabilidade-os-dados-disponiveis-ate-ao-momento-sao-convincentes","post_title":"Imunomodula\u00e7\u00e3o de primeira classe aliada \u00e0 praticabilidade \u2013 os dados dispon\u00edveis at\u00e9 ao momento s\u00e3o convincentes","href":"https:\/\/medizinonline.com\/pt-pt\/imunomodulacao-de-primeira-classe-aliada-a-praticabilidade-os-dados-disponiveis-ate-ao-momento-sao-convincentes\/"},"es_ES":{"locale":"es_ES","id":563806,"slug":"una-combinacion-de-inmunomodulacion-de-primera-clase-y-comodidad-los-datos-disponibles-hasta-la-fecha-son-convincentes","post_title":"Una combinaci\u00f3n de inmunomodulaci\u00f3n de primera clase y comodidad: los datos disponibles hasta la fecha son convincentes","href":"https:\/\/medizinonline.com\/es\/una-combinacion-de-inmunomodulacion-de-primera-clase-y-comodidad-los-datos-disponibles-hasta-la-fecha-son-convincentes\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/563814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=563814"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/563814\/revisions"}],"predecessor-version":[{"id":563821,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/563814\/revisions\/563821"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/563818"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=563814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=563814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=563814"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=563814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}